Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Akzo Nobel N.V. (AKZA.AS)
EUR57.60
+0.12 (+0.21%)
NL AMS Basic Materials Chemicals - Specialty
Address
Christian Neefestraat 2 1077 WW
Amsterdam, NL
Amsterdam, NL
CEO
Gregoire Poux-Guillaume
Website
akzonobel.com
IPO
1995-03-27
ISIN NL0013267909
Also trades on
Euronext Amsterdam · AKZA.AS (EUR)
Other OTC · AKZOF (USD)
Other OTC · AKZOY (USD)
Description
Akzo Nobel N.V. operates globally as a prominent manufacturer and distributor of paints and protective coatings. The company provides a comprehensive selection of decorative solutions, including paints, lacquers, and varnishes, alongside advanced mixing machinery and color systems tailored for the construction and renovation industries. Additionally, they produce specialized coatings for materials like metal and wood. Their portfolio also features high-performance coatings designed to protect and enhance a wide array of applications, from ships, cars, and aircraft to yachts, architectural elements, consumer goods, and oil and gas installations. These products are primarily sold under renowned brands such as Dulux, International, Sikkens, and Interpon. Founded in 1646 and headquartered in Amsterdam, the Netherlands, the company officially became Akzo Nobel N.V. in 1994, having previously been known as Akzo NV.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
EUR57.60
+0.12 (+0.21%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
781.5K
Beta
1.18
Float Shares
153.80M
Free Float %
89.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.12% | +25.21% | +31.64% | +10.13% | +17.17% | +10.91% | +9.51% | -8.30% | -37.64% | -5.86% | +205.82% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (2 ratings, all time)
Hold
Price Targets & DCF
Current price
57.60
DCF (Unlevered)
74.59
+29.5%
DCF (Levered)
77.51
+34.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
53% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 8 | 0 |
| Hold | 9 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
2.16
Grey zone
Piotroski F-Score
6 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Chemicals - Specialty: +4.7%-5.2% Q1'26: -8.7% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+16.8% ★ Q1'26: -12.9% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+11.6% ★ Q1'26: -5.4% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+11.5% ★ Q1'26: +10.4% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+10.1% ★ Q1'26: +8.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.3% Q1'26: -0.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×3.15× Q1'26: 4.48× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 18 Rev. Ana. 13 EPS Ana. |
Dec 2027 18 Rev. Ana. 13 EPS Ana. |
Dec 2028 15 Rev. Ana. 7 EPS Ana. |
Dec 2029 11 Rev. Ana. 2 EPS Ana. |
Dec 2030 7 Rev. Ana. 5 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
15.70B
est: 15.88B (-1.1%)
|
15.39B
est: 16.41B (-6.2%)
|
14.59B
est: 14.85B (-1.7%)
|
14.30B
est: 14.48B (-1.3%)
|
14.86B
est: 14.82B (+0.3%)
|
14.20B
est: 14.22B (-0.2%)
|
9.61B
est: 14.59B (-34.1%)
|
9.26B
est: 9.18B (+0.8%)
|
9.28B
est: 9.34B (-0.6%)
|
8.53B
est: 8.53B (0.0%)
|
9.59B
est: 9.60B (-0.1%)
|
10.85B
est: 10.82B (+0.3%)
|
10.67B
est: 10.69B (-0.2%)
|
10.71B
est: 10.64B (+0.7%)
|
10.16B
est: 10.23B (-0.7%)
|
10.02B
9.70B – 10.47B
-2.0% YoY
|
10.28B
9.79B – 10.78B
+2.6% YoY
|
10.46B
10.45B – 10.47B
+1.7% YoY
|
10.89B
10.46B – 11.40B
+4.1% YoY
|
11.12B
10.67B – 11.63B
+2.0% YoY
|
| EBITDA |
1.68B
est: 1.42B (+17.8%)
|
-539.00M
est: 1.11B (-148.7%)
|
1.49B
est: -1.38B (+207.9%)
|
1.67B
est: 1.24B (+34.9%)
|
2.14B
est: 1.34B (+59.3%)
|
1.21B
est: 1.85B (-34.4%)
|
1.09B
est: 1.78B (-38.4%)
|
854.00M
est: 810.07M (+5.4%)
|
1.26B
est: 7.10B (-82.3%)
|
1.33B
est: 971.84M (+36.5%)
|
1.53B
est: 1.03B (+48.9%)
|
1.05B
est: 1.06B (-0.7%)
|
1.41B
est: 1.71B (-17.4%)
|
1.40B
est: 1.71B (-18.1%)
|
1.54B
est: 1.64B (-5.8%)
|
1.60B
1.55B – 1.68B
-2.0% YoY
|
1.65B
1.57B – 1.72B
+2.6% YoY
|
1.67B
1.67B – 1.68B
+1.7% YoY
|
1.74B
1.67B – 1.82B
+4.1% YoY
|
1.78B
1.71B – 1.86B
+2.0% YoY
|
| EBIT |
1.18B
est: 1.32B (-10.6%)
|
-1.12B
est: 1.08B (-203.9%)
|
1.02B
est: -1.13B (+190.8%)
|
1.06B
est: 936.32M (+13.1%)
|
1.62B
est: 1.03B (+57.8%)
|
973.00M
est: 1.51B (-35.6%)
|
870.00M
est: 948.27M (-8.3%)
|
668.00M
est: 516.07M (+29.4%)
|
899.00M
est: 616.42M (+45.8%)
|
963.00M
est: 759.59M (+26.8%)
|
1.18B
est: 803.27M (+46.8%)
|
690.00M
est: 828.40M (-16.7%)
|
1.06B
est: 1.30B (-18.9%)
|
1.03B
est: 1.30B (-20.9%)
|
1.16B
est: 1.24B (-6.5%)
|
1.22B
1.18B – 1.27B
-2.0% YoY
|
1.25B
1.19B – 1.31B
+2.6% YoY
|
1.27B
1.27B – 1.27B
+1.7% YoY
|
1.33B
1.27B – 1.39B
+4.1% YoY
|
1.35B
1.30B – 1.42B
+2.0% YoY
|
| Net Income |
477.00M
est: 816.70M (-41.6%)
|
-2.17B
est: 492.98M (-540.0%)
|
724.00M
est: -1.96B (+136.9%)
|
546.00M
est: 707.62M (-22.8%)
|
979.00M
est: 567.28M (+72.6%)
|
970.00M
est: 939.84M (+3.2%)
|
832.00M
est: 996.56M (-16.5%)
|
6.67B
est: 520.45M (+1,182.4%)
|
539.00M
est: 6.80B (-92.1%)
|
630.00M
est: 486.82M (+29.4%)
|
829.00M
est: 514.82M (+61.0%)
|
352.00M
est: 530.92M (-33.7%)
|
442.00M
est: 592.00M (-25.3%)
|
542.00M
est: 697.05M (-22.2%)
|
635.00M
est: 622.00M (+2.1%)
|
683.15M
609.18M – 757.13M
+9.8% YoY
|
679.55M
666.09M – 857.40M
-0.5% YoY
|
744.54M
687.98M – 888.41M
+9.6% YoY
|
930.22M
881.57M – 986.51M
+24.9% YoY
|
776.11M
735.52M – 823.07M
-16.6% YoY
|
| SGA |
4.64B
est: 4.81B (-3.7%)
|
2.39B
est: 4.52B (-47.2%)
|
2.41B
est: 3.83B (-37.0%)
|
2.28B
est: 4.25B (-46.4%)
|
2.45B
est: 4.34B (-43.6%)
|
2.40B
est: 4.09B (-41.3%)
|
1.72B
est: 3.12B (-45.1%)
|
1.67B
est: 1.88B (-11.4%)
|
1.51B
est: 3.20B (-52.9%)
|
1.25B
est: 2.57B (-51.5%)
|
1.30B
est: 2.72B (-52.3%)
|
1.53B
est: 2.80B (-45.4%)
|
1.54B
est: 1.90B (-19.1%)
|
1.56B
est: 3.12B (-50.0%)
|
3.28B
est: 1.82B (+80.1%)
|
1.78B
1.72B – 1.86B
-2.0% YoY
|
1.83B
1.74B – 1.92B
+2.6% YoY
|
1.86B
1.86B – 1.86B
+1.7% YoY
|
1.94B
1.86B – 2.03B
+4.1% YoY
|
1.98B
1.90B – 2.07B
+2.0% YoY
|
| EPS |
2.30
est: 3.29 (-30.1%)
|
-10.29
est: 3.72 (-376.3%)
|
3.38
est: 3.18 (+6.4%)
|
2.51
est: 3.51 (-28.5%)
|
4.44
est: 3.63 (+22.3%)
|
4.35
est: 3.76 (+15.8%)
|
3.72
est: 3.85 (-3.5%)
|
29.46
est: 2.03 (+1,350.5%)
|
2.43
est: 3.04 (-20.0%)
|
3.29
est: 3.70 (-11.1%)
|
4.48
est: 4.10 (+9.3%)
|
2.01
est: 2.83 (-28.9%)
|
2.59
est: 3.47 (-25.4%)
|
3.17
est: 4.03 (-21.4%)
|
3.71
est: 3.63 (+2.1%)
|
3.86
3.54 – 4.40
+6.3% YoY
|
4.28
3.87 – 4.98
+10.7% YoY
|
4.60
4.00 – 5.16
+7.5% YoY
|
5.41
5.12 – 5.73
+17.5% YoY
|
4.51
4.27 – 4.78
-16.6% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-28 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-27 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-26 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-25 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-22 | A- | 4/5 | 5/5 | 4/5 | 4/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-19 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-18 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-14 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-13 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-12 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-11 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-05 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-05-04 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-15 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
493.26M
OE per share TTM
2.87
Owner's Yield
4.39%
Maintenance CapEx ratio
116.42%
Maint CapEx / Avg PPE
22.1%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
1
Total invested
33.98M
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2025 Q4
Investors holding
1
+0 vs prev Q
New positions
0
Closed positions
0
Increased
0
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ARISTOTLE CAPITAL MANAGEMENT, LLC | 488.8K -5.6K (-1.1%) | 33.98M -1.2M (-3.5%) | 0.29% -0.003 pp | 0.07% +0.000 pp | EUR63.10 -6.2% | 15 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
34.1K
Shares Outstanding
171.04M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Gregoire Poux-Guillaume | Chief Executive Officer & Chairman of the Management Board | 3M | male |
| Maarten Jan de Vries | Member of Management Board | 2M | male |
| Charlotte van Meer | General Counsel | — | female |
| Fredrik Westin | Chief Financial Officer | — | male |
| Kyung Seok Chae | Head Of Investor Relations | — | male |
| Armand Sohet | Chief Human Resources Officer | — | male |
| Wiebe Wiechers | Chief Development Officer | — | male |
| Charles W. Shaver | Chief Executive Officer of Specialty Chemicals | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AKZA.AS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
